1 year return (CAGR)
-36.21%
Tcr2 Therapeutics Inc Exchange (NASDAQ, USD)
TCRR
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-47.71%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
58.11M
Price/Sales
-
Ent value
93.84M
Price/Book
0.57
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
9.07%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 1.48 |
| Daily high | 1.48 |
| Daily low | 1.48 |
| Daily Volume | 0K |
| 1y analyst estimate | 6.43 |
| Beta | 1.93 |
| EPS (TTM) | -4.16 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| TCRR | S&P500 | |
| Current price drop from All-time high | -95.66% | -11.70% |
| Highest price drop | -97.56% | -56.47% |
| Date of highest drop | 22 Dec 2022 | 9 Mar 2009 |
| Avg drop from high | -54.98% | -10.68% |
| Avg time to new high | 47 days | 12 days |
| Max time to new high | 601 days | 1805 days |
News
No items found